drugset / Trial / NCT06291883

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

NCT06291883 ↗

Phase 1 Completed 26 enrolled Sheng-Teng Huang
RandomizedParallel-groupSingle-blindBasic science

Summary

These studies offer valuable insights into the potential development of KGR as a novel herbal-based preventive and therapeutic strategy against COVID-19.

Timeline

Start
2023-02-09
Primary completion
2023-04-18
Completion
2024-02-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Kang Guan Recipe Traditional medicine (herbal / TCM) 6 g —

Indications